T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies

Twenty-one pediatric and young adult patients (1.1–24.7 years) with hematologic malignancies underwent myeloablative T-cell replete haploidentical bone marrow transplant (haplo-BMT) between October 2015 to December 2019. Fifty-seven percent of the patients were ethnic or racial minorities. Thirteen...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanis, Emmanuel, Sapp, Lauren N., Reid, Susie Cienfuegos, Reddivalla, Naresh, Stea, Baldassarre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295947/
https://www.ncbi.nlm.nih.gov/pubmed/32582591
http://dx.doi.org/10.3389/fped.2020.00282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295947/
https://www.ncbi.nlm.nih.gov/pubmed/32582591
http://dx.doi.org/10.3389/fped.2020.00282

Ejemplares similares